Showing results (691-700 of 4,512) with videos related to

Sort By:
Pageof 452
Future Oncology (London, England)|December 6, 2019
Analysis of autophagy-related genes and associated noncoding RNAs and transcription factors in digestive system tumorsLiewen Lin, Ligang Xia, Donge Tang, et al.
Future Oncology (London, England)|September 25, 2020
Gilteritinib use in the treatment of relapsed or refractory acute myeloid leukemia with a FLT3 mutationOctavio Ballesta-López, Antonio Solana-Altabella, Juan Eduardo Megías-Vericat, et al.
Future Oncology (London, England)|September 25, 2020
Demographic factors associated with missed follow-up among solid tumor patients treated at a large multi-site academic institutionSamantha L Freije, Jordan A Holmes, Saleh Rachidi, et al.
Future Oncology (London, England)|September 17, 2020
PIVOT-10: Phase II study of bempegaldesleukin plus nivolumab in cisplatin-ineligible advanced urothelial cancerRobert A Huddart, Arlene O Siefker-Radtke, Arjun V Balar, et al.
Future Oncology (London, England)|January 6, 2021
LncRNA PCAT7 promotes the malignant progression of breast cancer by regulating ErbB/PI3K/Akt pathwayJiaoqun Zhou, Shiwei Zhang, Mingyuan Luo
Future Oncology (London, England)|January 6, 2021
Revisiting the role of TRAIL/TRAIL-R in cancer biology and therapyDeepika Singh, Mallika Tewari, Sunita Singh, et al.
Future Oncology (London, England)|January 6, 2021
Development and validation of a prognostic nomogram for gastric marginal zone lymphoma: a Surveillance, Epidemiology and End Results-based population studyMingliang Wang, Cheng Wu, Yida Lu, et al.
Future Oncology (London, England)|December 28, 2020
Potential alteration of tumor microenvironments by β-mercaptoethanolRobert E Click
Future Oncology (London, England)|December 22, 2020
Radiology management of a 'breast unit' during COVID-19 pandemic: a single institution experienceChristine Salem, Marie-Ange Hajj, Hampig Kourié, et al.
Future Oncology (London, England)|October 23, 2020
Optimizing therapy sequence to prevent patient attrition in EGFR mutation-positive advanced or metastatic NSCLCJulia Roeper, Sylke Kurz, Christian Grohé, et al.
Pageof 452